N-(4-Methyl-pyridin-2-yl)-isonicotinamide, 250mg

trans-4-Pentylcyclohexanecarboxylic acid, 97%, 100g

(2E)-1-(3-bromophenyl)-3-(4-bromophenyl)prop-2-en-1-one, 95.0%, 2g

N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine, 98%, 25g

delta-Hexanolactone>99.0%(GC)25g

N-[-4-(2-Bromoethoxy)phenyl]acetamide, 1g

N,N,N-Trimethyladamantan-1-aminium hydroxide, 25% in water, 500g

N-(furan-2-ylmethyl)-2-(2-methyl-1H-indol-3-yl)ethan-1-amine hydrochloride, 95.0%, 250mg

Methyl 2-amino-5-bromobenzoate, 98.0%, 100g

DI-TERT-BUTYL(2',4',6'-TRIISOPROPYL-[1,1'-BIPHENYL]-2-YL)PHOSPHINE, 95%, 25g

H-Pro-OBzl.HCl, 98%, 5g

Methyl 5-bromo-2-oxoindoline-7-carboxylate, 95.0%, 1g